cefuroxime has been researched along with Shock, Septic in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "a 60-year-old female admitted to the hospital with tonsillitis acuta verified by strep-A test was initially treated with V-penicillin, but developed septic shock and disseminated intravascular coagulation (DIC), and treatment was changed to cefuroxime and clindamycin." | 3.75 | [Streptococcus pyogenes infection with tonsillar focus as possible cause of septic shock]. ( Alimoradi, J; Haraszuk, J; Jeppesen, J; Lisby, G, 2009) |
| "In addition, septic shock occurred in 6 cases (2." | 2.73 | Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. ( Falagas, M; Falagas, ME; Geroulanos, S; Karatza, D; Kriaras, I; Mastoraki, E; Michalopoulos, A; Mouchtouri, E, 2008) |
| "The authors report a case of septic arthritis caused by V." | 1.42 | Septic arthritis and subsequent fatal septic shock caused by Vibrio vulnificus infection. ( Asmussen Andreasen, R; Emamifar, A; Jensen Hansen, IM; Skaarup Andersen, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emamifar, A | 1 |
| Asmussen Andreasen, R | 1 |
| Skaarup Andersen, N | 1 |
| Jensen Hansen, IM | 1 |
| Alimoradi, J | 1 |
| Lisby, G | 1 |
| Jeppesen, J | 1 |
| Haraszuk, J | 1 |
| Mastoraki, E | 1 |
| Michalopoulos, A | 1 |
| Kriaras, I | 1 |
| Mouchtouri, E | 1 |
| Falagas, ME | 1 |
| Falagas, M | 1 |
| Karatza, D | 1 |
| Geroulanos, S | 1 |
1 trial available for cefuroxime and Shock, Septic
| Article | Year |
|---|---|
Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Coronary Artery Bypass; Drug | 2008 |
2 other studies available for cefuroxime and Shock, Septic
| Article | Year |
|---|---|
Septic arthritis and subsequent fatal septic shock caused by Vibrio vulnificus infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Cardiotonic Agents; Cefuroxime; Den | 2015 |
[Streptococcus pyogenes infection with tonsillar focus as possible cause of septic shock].
Topics: Anti-Bacterial Agents; Cefuroxime; Clindamycin; Disseminated Intravascular Coagulation; Female; Huma | 2009 |